Lamers CHJ - Search Results

1

Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies.

van Putten EHP, Kleijn A, van Beusechem VW, Noske D, Lamers CHJ, de Goede AL, Idema S, Hoefnagel D, Kloezeman JJ, Fueyo J, Lang FF, Teunissen CE, Vernhout RM, Bakker C, Gerritsen W, Curiel DT, Vulto A, Lamfers MLM, Dirven CMF. van Putten EHP, et al. Among authors: lamers chj. Clin Cancer Res. 2022 Apr 14;28(8):1572-1585. doi: 10.1158/1078-0432.CCR-21-3324. Clin Cancer Res. 2022. PMID: 35176144 Free PMC article. Clinical Trial.

2

Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses.

Portielje JE, Lamers CH, Kruit WH, Sparreboom A, Bolhuis RL, Stoter G, Huber C, Gratama JW. Portielje JE, et al. Clin Cancer Res. 2003 Jan;9(1):76-83. Clin Cancer Res. 2003. PMID: 12538454 Clinical Trial.

3

Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity.

Lamers CH, Sleijfer S, van Steenbergen S, van Elzakker P, van Krimpen B, Groot C, Vulto A, den Bakker M, Oosterwijk E, Debets R, Gratama JW. Lamers CH, et al. Mol Ther. 2013 Apr;21(4):904-12. doi: 10.1038/mt.2013.17. Epub 2013 Feb 19. Mol Ther. 2013. PMID: 23423337 Free PMC article. Clinical Trial.

4

Long-term stability of T-cell activation and transduction components critical to the processing of clinical batches of gene-engineered T cells.

Lamers CH, van Elzakker P, van Steenbergen SC, Luider BA, Groot C, van Krimpen BA, Vulto A, Sleijfer S, Debets R, Gratama JW. Lamers CH, et al. Cytotherapy. 2013 May;15(5):620-6. doi: 10.1016/j.jcyt.2012.12.006. Epub 2013 Feb 4. Cytotherapy. 2013. PMID: 23388583 Clinical Trial.

5

Phase I study of RGB-286638, a novel, multitargeted cyclin-dependent kinase inhibitor in patients with solid tumors.

van der Biessen DA, Burger H, de Bruijn P, Lamers CH, Naus N, Loferer H, Wiemer EA, Mathijssen RH, de Jonge MJ. van der Biessen DA, et al. Clin Cancer Res. 2014 Sep 15;20(18):4776-83. doi: 10.1158/1078-0432.CCR-14-0325. Epub 2014 Jul 14. Clin Cancer Res. 2014. PMID: 25024258 Clinical Trial.

6

T-cell Receptors for Clinical Therapy: In Vitro Assessment of Toxicity Risk.

Kunert A, Obenaus M, Lamers CHJ, Blankenstein T, Debets R. Kunert A, et al. Among authors: lamers chj. Clin Cancer Res. 2017 Oct 15;23(20):6012-6020. doi: 10.1158/1078-0432.CCR-17-1012. Epub 2017 Jun 23. Clin Cancer Res. 2017. PMID: 28645940 Review.

7

Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience.

Lamers CH, Sleijfer S, Vulto AG, Kruit WH, Kliffen M, Debets R, Gratama JW, Stoter G, Oosterwijk E. Lamers CH, et al. J Clin Oncol. 2006 May 1;24(13):e20-2. doi: 10.1200/JCO.2006.05.9964. J Clin Oncol. 2006. PMID: 16648493 No abstract available.

8

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients.

Bleumer I, Knuth A, Oosterwijk E, Hofmann R, Varga Z, Lamers C, Kruit W, Melchior S, Mala C, Ullrich S, De Mulder P, Mulders PF, Beck J. Bleumer I, et al. Br J Cancer. 2004 Mar 8;90(5):985-90. doi: 10.1038/sj.bjc.6601617. Br J Cancer. 2004. PMID: 14997194 Free PMC article. Clinical Trial.

9

Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trials.

Davis JL, Theoret MR, Zheng Z, Lamers CH, Rosenberg SA, Morgan RA. Davis JL, et al. Clin Cancer Res. 2010 Dec 1;16(23):5852-61. doi: 10.1158/1078-0432.CCR-10-1280. Clin Cancer Res. 2010. PMID: 21138872 Free PMC article. Clinical Trial.

10

A phase I/II study of multicyclic dose-intensive chemotherapy supported with G-CSF, or G-CSF and haematopoietic progenitor cells in whole blood, in two consecutive cohorts of patients.

de Wit R, Kruit WH, Lamers CH, van 't Veer MB, Luyten AA, van Beurden V, Harteveld M, Planting AS, Schmitz PI, Stoter G, Bolhuis RL, Verweij J. de Wit R, et al. Br J Cancer. 1998 Jun;77(12):2363-6. doi: 10.1038/bjc.1998.392. Br J Cancer. 1998. PMID: 9649159 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page